PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
31-Jul-2020 Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer AstraZeneca
31-Jul-2020 BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma BioNTech
31-Jul-2020 Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate Pfizer Inc
30-Jul-2020 Chi-Med Reports 2020 Interim Results and Provides Updates on Key Clinical Programs Chi-Med
30-Jul-2020 Oculis to Present at the LifeSci Partners Private Company Virtual Summer Symposium Oculis
30-Jul-2020 New data in NEJM shows nirsevimab reduced respiratory syncytial virus infections (lower respiratory tract infections) requiring medical care in healthy premature infants sanofi
30-Jul-2020 Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® Acacia Pharma Group plc
30-Jul-2020 Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications Oculis
30-Jul-2020 New clinical study shows heat combined with TENS provides 32% reduction in chronic pain OMRON Healthcare Europe
30-Jul-2020 Chiesi publishes its annual report: Group generates almost €2 billion turnover and obtains B Corp certification in 2019 Chiesi Group
30-Jul-2020 SAVORTEX RESPONDS TO COVID-19 WITH LAUNCH OF REVOLUTIONARY NEW ‘SMART’ HAND SANITISER SAVORTEX
30-Jul-2020 Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited Jubilant Biosys Limited
30-Jul-2020 NORGINE RECEIVES RoSPA GOLD MEDAL FOR HEALTH AND SAFETY SIXTH YEAR IN A ROW Norgine
30-Jul-2020 European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis Celltrion Healthcare
29-Jul-2020 Cadila Pharmaceuticals expands oncology portfolio with biosimilar cancer drug Bevaro™ CADILA PHARMACEUTICALS LTD
28-Jul-2020 Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd Swedish Biomimetics 3000®
28-Jul-2020 Chiesi publishes its annual report: Group generates almost €2 billion turnover and obtains B Corp certification in 2019 Chiesi Group
28-Jul-2020 Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical bacterial infections Destiny Pharma plc
28-Jul-2020 Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China Chi-Med
28-Jul-2020 Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease AstraZeneca